Top 18 B Group INC Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| ADMA | ADMA BIOLOGICS INC | 15.5% | 3.26M | $27.3M | +1.71%(+55.00K) | $17.18(-44.84%) | 2026-06-30 | |
| PALI | PALISADE BIO INC | 13.54% | 11.41M | $23.9M | +0.00%(+0) | $1.87(+14.69%) | 2026-06-30 | |
| NRXP | NRX PHARMACEUTICALS INC | 9.5% | 4.09M | $16.7M | +36.39%(+1.09M) | $3.23(+3.43%) | 2026-06-30 | |
| SNSE | FAETH THERAPEUTICS INC | 8.66% | 610.2K | $15.3M | new | $24.00(+8.17%) | 2026-06-30 | |
| TSHA | TAYSHA GENE THERAPIES INC | 6.96% | 1.80M | $12.3M | +0.00%(+0) | $1.90(+215.97%) | 2026-06-30 | |
| PRAX | PRAXIS PRECISION MEDICINES I | 6.32% | 33.2K | $11.1M | +0.00%(+0) | $56.11(+579.47%) | 2026-06-30 | |
| CLLS | CELLECTIS S A | 5.59% | 3.28M | $9.8M | +0.00%(+0) | $1.94(+64.06%) | 2026-06-30 | |
| ZLAB | ZAI LAB LTD | 4.86% | 450.6K | $8.6M | +0.00%(+0) | $24.39(+6.75%) | 2026-06-30 | |
| GPCR | STRUCTURE THERAPEUTICS INC | 4.26% | 140.0K | $7.5M | +9.80%(+12.50K) | $51.48(+6.25%) | 2026-06-30 | |
| ORKA | ORUKA THERAPEUTICS INC | 4.05% | 75.0K | $7.1M | +0.00%(+0) | $16.06(+557.40%) | 2026-06-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative | Since First Filing (6 quarters) |
|---|---|---|---|---|---|
| Top 20 Holdings Weighted | โ | โ | โ | โ | +36.35% |
| Top 20 Holdings Unweighted | โ | โ | โ | โ | +134.92% |
B Group INC reports $213.01M in US-listed equity holdings across 18 positions in its most recent 13F filing. Its largest disclosed positions are ADMA (15.5%), PALI (13.5%) and NRXP (9.5%). The top 20 holdings account for 100.01% of reported assets. Its disclosed equity book has returned +36.35% cumulatively over 6 quarters. Figures reflect the Q2 2026 filing.
Portfolio changes
Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.
Sign up free to track B Group INC, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from B Group INCโs Form 13F filings with the U.S. Securities and Exchange Commission (CIK 2043476). View B Group INCโs 13F filings on SEC